Ventricular septal rupture remains one of the most devastating complications of acute myocardial infarction. Although early coronary reperfusion has reduced its incidence to below 0.5%, its occurrence continues to be associated with exceptionally high mortality, exceeding 90% without repair and remaining between 30% and 50% even after surgical treatment. This apparent paradox reflects the fact that the problem has never been limited to the presence of an interventricular communication, but rather to the biological setting in which it develops: a ventricle undergoing extensive necrosis, inflammation, and structural degradation, where every attempt at repair becomes a constant struggle against tissue friability.

For decades, the fundamental principles of surgical treatment for postinfarction VSR have evolved very little. From the classical Daggett techniques to the infarct exclusion technique described by David, all approaches pursue the same objective: isolating the defect with a patch anchored to apparently viable myocardium while avoiding direct suturing into necrotic tissue. However, they also share the same limitation. To a greater or lesser extent, successful repair still depends on the ability of recently infarcted myocardium to withstand mechanical stress. This is precisely the source of many complications that continue to influence patient prognosis, including dehiscence, interference with the subvalvular apparatus, residual shunting, and early repair failure.

For this reason, one of the most persistent controversies in the management of this complication has focused not on how to close the defect, but on when to do so. Delaying surgery allows the necrotic tissue to mature into a more consistent scar, thereby facilitating a safer repair. Nevertheless, waiting is not without risk. Many patients die before reaching this ideal window because of progressive cardiogenic shock, multiorgan dysfunction, or refractory heart failure. For years, postinfarction VSR surgery has remained trapped between two equally serious threats: operating too early means suturing tissue that cannot support the repair, whereas waiting too long means accepting that a substantial proportion of patients will never reach the operating room. Some groups have proposed an intermediate solution based on mechanical circulatory support to bridge patients to delayed repair, although the morbidity associated with these devices cannot be overlooked.

Against this background, Song et al. present an especially appealing proposal because it addresses the problem from an entirely different perspective. Rather than focusing on improving the patch or refining the suturing technique, they introduce an element borrowed from structural heart intervention: a patent ductus arteriosus occluder deployed under direct vision during open surgery and used as a supporting structure for the reconstruction. A pericardial patch is subsequently secured to the device, creating what the authors call the SurCOP procedure—Surgical repair Combining an Occluder and a Patch.

The concept is, at the very least, ingenious. The occluder is deployed under direct vision and becomes a true mechanical framework supporting the surgical repair. Conceptually, this transfers a technology developed for interventional procedures into open surgery, combining the advantages of both approaches. The device provides three-dimensional stability, preserves the geometry of the defect, and distributes traction forces across a broader area. Meanwhile, the surgical approach allows the addition of a patch to achieve sealing and enables concomitant procedures when required, including CABG, valve repair, or ventricular reconstruction.

This is probably the most innovative feature of the study and, paradoxically, the one that receives the least attention from the authors. Throughout the manuscript, the emphasis repeatedly falls on early mortality and optimal surgical timing, whereas the true innovation lies in rethinking the repair itself. Conventional surgery requires diseased tissue to withstand the tension generated by the sutures; the SurCOP strategy attempts to reduce that tension by redistributing it through a rigid supporting structure. This is not simply the addition of a device to a conventional procedure, but a modification of how mechanical forces are transmitted to infarcted myocardium.

The study included 60 patients who underwent the SurCOP procedure between 2017 and 2025 at three Chinese centres, with a 30-day mortality of 23.3%. At first glance, this figure appears remarkably favourable compared with large contemporary series, in which surgical mortality remains approximately 40%. The authors interpret this result as evidence that the new technique may facilitate earlier intervention without compromising outcomes, further supporting their argument through comparison with a historical cohort treated with conventional repair at their own institution.

However, these findings should be interpreted cautiously. The control group cannot be considered a strictly comparable cohort. Patients undergoing conventional repair were operated on significantly later after AMI, differed meaningfully in IABP use, diabetes, and shock status, and belonged to a different treatment period. Consequently, it is extremely difficult to attribute the observed differences exclusively to the new technique. This is even more relevant because 30-day mortality was virtually identical between the two groups: 23.3% versus 25%. From a methodological perspective, the study does not demonstrate that SurCOP is superior to conventional repair. It does, however, suggest that the technique is feasible, reproducible, and sufficiently safe for use in very high-risk patients without worsening outcomes that have historically remained discouraging.

The most interesting message of the study may therefore not be that the procedure reduces mortality, but that it changes how we understand postinfarction VSR repair. For decades, necrotic tissue has been regarded as the principal enemy. Song et al. propose a different hypothesis: the true enemy may be the concentration of mechanical stress on that tissue. If this concept is correct, the future of surgery may lie in designing systems that distribute mechanical forces more effectively during healing. More than the specific mortality figures, this concept represents the true contribution of the SurCOP procedure.

COMMENTARY:

Beyond the hybrid procedure itself, the other major issue addressed by the study is optimal surgical timing. Few decisions in cardiac surgery generate as much uncertainty as the indication for surgery in postinfarction VSR. Current clinical guidelines provide a seemingly straightforward recommendation: immediate surgery in the presence of refractory shock or progressive haemodynamic deterioration and, when the patient’s clinical condition allows, delayed repair to facilitate organization of the necrotic tissue. Translating this principle into daily practice, however, is exceptionally complex. These patients commonly present with rapidly progressive heart failure, dependence on circulatory support, and a delicate balance between the risks of early surgery and those of a potentially fatal delay.

The data reported by Song et al. once again confirm a well-established observation. Mortality reached 66.7% when surgery was performed during the first week after AMI, falling to approximately 19% when the procedure was undertaken between 7 and 14 days or beyond 2 weeks. Multivariable analysis also identified three independent prognostic factors: age, preoperative renal function, and the interval between AMI and surgery. None of these findings is particularly surprising. In fact, they closely reproduce the conclusions previously reported by the Society of Thoracic Surgeons database and by the most recent European consensus documents on the mechanical complications of AMI.

This is precisely why the authors’ principal message should be interpreted with caution. The study suggests that the SurCOP technique may permit earlier surgery by reducing tension on the infarcted myocardium. This hypothesis is biomechanically sound and probably represents the most promising feature of the procedure. Nevertheless, the study does not demonstrate it conclusively. Paradoxically, the series itself confirms that the best outcomes are still achieved when surgery can be delayed for at least 1 week. In other words, the new technique does not alter the fundamental biological principle governing this condition: infarcted tissue needs time to gain consistency. SurCOP may reduce stress across the repair, but it does not accelerate myocardial healing.

This distinction is important because it prevents the procedure from being interpreted as a solution that eliminates the timing dilemma characteristic of postinfarction VSR. The SurCOP strategy probably does not replace delayed surgery when waiting is feasible. Instead, it provides an additional tool for patients in whom such a delay is not possible. Put differently, it does not change the biology of the disease, but it may widen the safety margin for surgery during earlier phases. This nuance could have been explored in greater depth in the manuscript and is clinically far more relevant than a simple comparison of mortality percentages.

Another particularly interesting aspect receives little attention in the article. Surgical repair failure has traditionally been attributed directly to myocardial friability. However, factors related to defect geometry probably also play an important role. Postinfarction VSRs rarely have regular margins. They are usually irregular, serpiginous channels surrounded by heterogeneous tissue, in which mechanical stress is unevenly distributed. In this setting, a centrally positioned occluder may function as a true load-distribution structure, stabilizing the defect even before the patch provides definitive sealing.

Nevertheless, the enthusiasm generated by this innovation must be balanced against a critical appraisal of the study’s limitations. This was a retrospective series of only 60 patients treated by a single surgical team, although the procedures were performed across several hospitals. The lack of randomization, small sample size, and use of a historical comparison group substantially weaken the conclusions. A significant selection bias also cannot be excluded. Patients considered suitable candidates for the SurCOP strategy may have differed, at least in part, from those treated with conventional techniques. Potentially relevant variables such as actual infarct size, the extent of septal necrosis, the precise location of the defect, and the quality of the remaining tissue were not analysed, despite their clear influence on surgical outcomes.

The follow-up reported by the authors is also of interest. Over a median period of more than 2 years, no device migration, occluder-related infection, or need for reoperation was documented. Although these findings are reassuring, the number of patients remains too small to draw definitive conclusions regarding the durability of a technique that introduces a foreign body into an environment exposed to substantial geometric changes during both the cardiac cycle and ventricular remodelling. Its long-term behaviour, the potential interaction between the occluder and the pericardial patch, and the functional evolution of the left ventricle after complete infarct healing will be particularly important areas for future assessment.

Ultimately, the SurCOP procedure is one of those innovations that attracts attention not because of its technical complexity, but because of the simplicity of its underlying concept. Its main merit lies in challenging a principle that had been accepted for decades: that the entire stability of the repair had to depend exclusively on the patch and sutures. By incorporating a structural heart device deployed under direct vision and sealed with a patch as a supporting element, the authors introduce a new conceptual approach to postinfarction VSR. In the future, we may see increasing integration between structural intervention devices and open surgical techniques, leading to genuinely hybrid procedures in which each technology contributes what it was best designed to provide.24

REFERENCE:

Song C, Zhang N, Cao J, Guo J, Shi J, Xiao K, Liu C. The SurCOP Procedure for Ventricular Septal Rupture: Analysis of Outcomes and Preoperative Risk Factors to Guide Surgical Timing. Interdiscip Cardiovasc Thorac Surg. 2026 Jun 9;41(6):ivag129. doi: 10.1093/icvts/ivag129.